Neuromodulation Devices: World Market Prospects 2011-2021 - offers a comprehensive view of the global neuromodulation devices market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the neuromodulation devices market in 2011 to be worth $3.05bn. The market has significant potential for growth with the increasing global burden of neurological and cardiovascular disorders, especially in the emerging economies. Growth in this market will also be driven by the approval and launch of neuromodulation devices that are more effective and involve a more simplified, less-invasive implantation procedure.

Neuromodulation is one of the fastest growing sectors of the medical device market. Neuromodulation is a rapidly evolving medical technique that provides symptomatic relief through the alteration, or modulation, of nerve system function. It works by either stimulating nerves to produce a natural biological response or by applying small doses of pharmaceutical agents directly to the site of action.

Visiongain's research suggests that the neuromodulation devices market will benefit from the growth of healthcare markets in the emerging economies. The growth in emerging markets such as India and China will be driven by an aging population that will increase demand for newer treatment options for age-related diseases. India's expanding economy is likely to see an increased wealth among the population, specifically within the middle class, which will cause an increased adoption of westernised lifestyles. Diseases such as obesity and coronary heart disease will therefore become more prevalent. The neuromodulation devices market in the emerging economies will also benefit from a rise in demand for non-invasive treatment options and medical tourism.

The Neuromodulation Devices: World Market Prospects 2011-2021 examines the spinal cord stimulaiton, deep brain stimulation and vagus nerve stimulation with respect to the market size, leading companies and products, and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2021, primarily driven by a rise in age-related diseases, approval of innovative devices, and increased patient adoption of existing and newly-marketed products.

How will the neuromodulation devices market develop this decade? Which regions offer the most significant growth opportunities between 2011 and 2021? Which of the neuromodulation devices submarkets are growing most strongly? Who are the leading companies in the neuromodulation devices market? What are the most promising neuromodulation devices in development and when are they expected to receive market approval?

Visiongain answers these critical questions and many more through the in-depth analyses that are presented in this report.

Read more: http://www.sacbee.com/2011/11/28/4083704/neuromodulation-devices-world.html#ixzz1faH35paB

Comments

Search RSS

All rights reserved."